Yue Li
12Patents
3h-index
58Co-inventors
63Inventor score
Filing activity: Apr 11, 2003 → May 17, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8685980B2 | Pyrrolopyrimidine compounds and their uses | Human Necessities | 27 | Active |
| US8410264B2 | Heterocyclic oxime compounds | Human Necessities | 8 | Active |
| US9416136B2 | Pyrrolopyrimidine compounds and their uses | Human Necessities | 3 | Active |
| US8507676B2 | Heterocyclic oxime compounds | Human Necessities | 2 | Active |
| US8497368B2 | Heterocyclic hydrazone compounds | Human Necessities | 2 | Active |
| US7375131B2 | NF-κB inhibitors | Human Necessities | 2 | Expired |
| US8206718B2 | Expression and export of angiogenesis inhibitors as immunofusins | Emerging Cross-Sectional Technologies | 2 | Active |
| US11970480B2 | Heterocyclic amides useful as protein modulators | Emerging Cross-Sectional Technologies | 1 | Active |
| US8703908B2 | Expression and export of angiogenesis inhibitors as immunofusins | Emerging Cross-Sectional Technologies | 1 | Active |
| US10975287B2 | Heterocyclic amides useful as protein modulators | Fixed Constructions | 0 | Active |
| US7183311B2 | NF-κB inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US11976057B2 | MrgX2 antagonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.